about
Only one splice variant of the human TAZ gene encodes a functional protein with a role in cardiolipin metabolismCardiac and skeletal muscle defects in a mouse model of human Barth syndromeThe enigmatic role of tafazzin in cardiolipin metabolismMTCH2/MIMP is a major facilitator of tBID recruitment to mitochondriaSystems genetics of metabolism: the use of the BXD murine reference panel for multiscalar integration of traitsCalorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese HumansDistinct effects of tafazzin deletion in differentiated and undifferentiated mitochondria.Mitochondrial response to nutrient availability and its role in metabolic disease.A sensitive mass spectrometry platform identifies metabolic changes of life history traits in C. elegansA method to identify and validate mitochondrial modulators using mammalian cells and the worm C. elegans.The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways.The NAD(+)/Sirtuin Pathway Modulates Longevity through Activation of Mitochondrial UPR and FOXO Signaling.Bloodspot assay using HPLC-tandem mass spectrometry for detection of Barth syndrome.Cardiolipin, the heart of mitochondrial metabolism.PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activationCardiomyocyte-specific miRNA-30c over-expression causes dilated cardiomyopathy.The metabolic footprint of aging in miceProlonged daily light exposure increases body fat mass through attenuation of brown adipose tissue activity.Antibiotic use and abuse: a threat to mitochondria and chloroplasts with impact on research, health, and environmentThe NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity.Mitonuclear protein imbalance as a conserved longevity mechanism.Mutations in LPIN1 cause recurrent acute myoglobinuria in childhood.A screening-based platform for the assessment of cellular respiration in Caenorhabditis elegans.Atypical Clinical Presentations of TAZ Mutations: An Underdiagnosed Cause of Growth Retardation?Metabolic networks of longevityNAD⁺ metabolism: a therapeutic target for age-related metabolic disease.Pharmacological approaches to restore mitochondrial function.The dynamics of cardiolipin synthesis post-mitochondrial fusion.Mitochondrial quality control pathways as determinants of metabolic health.Mitochondrial fission: firing up mitochondria in brown adipose tissue.Barth syndrome: cellular compensation of mitochondrial dysfunction and apoptosis inhibition due to changes in cardiolipin remodeling linked to tafazzin (TAZ) gene mutation.Deletion of the cardiolipin-specific phospholipase Cld1 rescues growth and life span defects in the tafazzin mutant: implications for Barth syndrome.Cardiolipin molecular species with shorter acyl chains accumulate in Saccharomyces cerevisiae mutants lacking the acyl coenzyme A-binding protein Acb1p: new insights into acyl chain remodeling of cardiolipin.BID is cleaved by caspase-8 within a native complex on the mitochondrial membrane.Obesity: New life for antidiabetic drugs.The two-faced progeria gene and its implications in aging and metabolism.Laminar shear stress inhibits endothelial cell metabolism via KLF2-mediated repression of PFKFB3.Identification and characterization of human cardiolipin synthase.Cardiolipin and monolysocardiolipin analysis in fibroblasts, lymphocytes, and tissues using high-performance liquid chromatography-mass spectrometry as a diagnostic test for Barth syndrome.Mutations in LPIN1 Cause Recurrent Acute Myoglobinuria in Childhood.
P50
Q24317315-6F7C8797-4E97-473F-960E-8836D566235FQ24598420-DC37D913-6FE6-466D-BFCC-3520BA7C878FQ28252517-31D37166-298D-460C-AD8B-D5E0267FF4BCQ28594262-291FF083-DC46-4182-A141-45F89C5468D2Q30485668-3F858DD4-00DA-4EC5-903B-70687A722BBEQ32774312-97E9E0EA-E641-48A1-9E5A-10005B5247DEQ33396387-B76489E4-2CFF-4F80-8A7D-1E323B5845A4Q33623344-B54DBA58-1996-4CD9-8A90-7DAFFB5B771BQ33729188-154A24B1-9F8A-4DCA-9E9E-2FC7FDF5687AQ33749557-109B4588-3C5D-474E-BD23-C33B818495BFQ33779682-3B0D9356-14E1-49D1-A17A-306BA928387BQ34358623-3374B418-6E79-4CC3-A37F-0B8B08810B89Q34723466-581F9DB4-3652-49D3-BCB1-23F3A609B3E2Q34772063-BA462277-DC3D-4937-9963-66EE6FB20615Q34911412-8321C835-900B-49DA-AB40-0DAAE35E81F0Q35161937-D7CDD656-1ECF-4909-A878-CDA586F3F7ABQ35551597-CB32F771-B9DA-4CDE-BCA0-650F48CF7A9FQ35669324-0401F2EC-8BE8-425D-A3CA-29EAC88E1CE7Q36421608-61607C64-4570-435E-A17B-A6820947BA46Q36739590-923C32A6-57EE-473D-AC89-65B7EE450F0BQ36873369-0123D0A7-7938-4FDF-985D-6FFCD907CB3CQ36923822-871B9289-A5DF-4A65-B9C1-62E67F0683C0Q37292765-C78ED3D5-1243-4B27-8B95-70660C14FFD5Q37329161-5C85CFFC-21A4-4CCC-AD44-3F7C909242FEQ37367589-0D7372AF-9231-4835-9E23-DF20034C8EE9Q37381724-201A10F1-08E7-4075-81C9-695D1898C0C1Q37497833-8D879851-4053-486D-95BD-BE581F42D413Q38431805-DB82386E-6066-4936-8EF1-65D8CE667D3EQ38502547-7BB51786-BEE4-45D2-9D21-7A2CAA712FA7Q38797569-652CBBC1-CB32-40E9-8FD3-6D2700DF1D22Q39176896-195F7EDE-9E7B-4A4A-A3E9-2FBD70E57250Q41925566-130CE6F3-BF52-43FA-A0DD-A355E4C832EAQ42684081-1D094BB8-69AD-41DD-8781-D3190819E273Q42790840-C1C7CD96-6ED6-405B-AF21-DE1A93994362Q42842891-16EB0347-CB51-4E9F-920A-3169DC146B1AQ42962544-5D2C272A-2896-47DA-8908-666AE44B109EQ43710397-6D891662-A229-4374-8215-754AB8CF1A11Q45345669-FA12A799-B803-4EF3-8629-DA93B5272A8CQ46005237-47DDC906-9F6D-4CF9-AD6D-FD6A0DE7FDF8Q46797753-14F7CD2E-E396-40DD-9549-363E2022BC84
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Riekelt H Houtkooper
@ast
Riekelt H Houtkooper
@en
Riekelt H Houtkooper
@es
Riekelt H Houtkooper
@nl
Riekelt H Houtkooper
@sl
type
label
Riekelt H Houtkooper
@ast
Riekelt H Houtkooper
@en
Riekelt H Houtkooper
@es
Riekelt H Houtkooper
@nl
Riekelt H Houtkooper
@sl
altLabel
Riekelt H. Houtkooper
@en
prefLabel
Riekelt H Houtkooper
@ast
Riekelt H Houtkooper
@en
Riekelt H Houtkooper
@es
Riekelt H Houtkooper
@nl
Riekelt H Houtkooper
@sl
P106
P21
P31
P496
0000-0001-9961-0842
P569
2000-01-01T00:00:00Z